Xcout Intel
Phaeosynt competitors & alternatives
The 12 closest competitors and alternatives to Phaeosynt among biotechnology companies — ranked by similarity to what Phaeosynt actually does, not by market-cap band.
Subscribe to see Phaeosynt’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Phaeosynt
Headquartered in Hanover, Germany, Phaeosynt is a biotechnology company founded to produce animal-free antibodies using diatoms instead of traditional methods.
Phaeosynt at a glance
Phaeosynt is a biotechnology company headquartered in Germany. Its most recent funding round, Pre-Seed, raised $1.8M in February 2025. Xcout tracks 3 named people at Phaeosynt, including Stephanie Pfeil-Coenen (CEO, Geschäftsführung, Finanzen, Vertrieb).
Phaeosynt leadership
- Stephanie Pfeil-CoenenCEO, Geschäftsführung, Finanzen, Vertrieb
- Dr. Alina EilersCOO, Geschäftsführung, Kooperationen, QM
- Stas HansCTO, Forschung, Entwicklung
Phaeosynt funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $1.8M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Phaeosynt competitors
Ranked by semantic similarity — how close each company is to Phaeosynt by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Biotech
Plant Advanced Technologies (PAT) is a plant biotechnology company that produces rare and innovative active ingredients for the cosmetic, pharmaceutical, and agrochemical markets. The company develops proprietary extraction technologies and participates in collaborative research projects to supply high-value plant-based compounds while preserving biodiversity.
Similar biotechnology company
Valanx Biotech is a Vienna-based biotechnology company with around 15 employees, specializing in specific, fast, and cost-effective protein conjugation technologies.
Similar biotechnology company
JeNaCell is a German biotech company founded in 2012 and headquartered in Jena, Germany, specializing in biomaterials. The company was acquired by Evonik to expand its biomaterials portfolio while maintaining its development and production site in Jena.
Biotech
Wuhan Healthgen Biotechnology Corp. develops and manufactures plant-derived recombinant human serum albumin and related biopharmaceutical materials. Its products serve biopharmaceutical manufacturers, including applications in cell culture, drug formulation, vaccines, and diagnostics.
Biotechnology & Pharmaceuticals
Creative Biolabs is a biotechnology company that provides custom antibody development, engineering, and manufacturing services for pharmaceutical and research projects.
HealthTech
Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.
Diagnostics
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
Similar biotechnology company
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
Similar biotechnology company
Cardior Pharmaceuticals GmbH is a clinical-stage biopharmaceutical company headquartered in Hannover, Germany. Established in 2016, the company focuses on discovering and developing RNA-based therapeutics for the prevention and treatment of heart diseases.
Biotech
Infinimmune is an Alameda, California-based biotechnology company founded in 2022 that develops human-derived antibody medicines and holds a massive database of paired heavy and light sequences.
Similar biotechnology company
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Phaeosynt and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Phaeosyntand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →